Published in JAMA on July 17, 2002
The 2012 hormone therapy position statement of: The North American Menopause Society. Menopause (2012) 4.04
Sleep complaints in community-living older persons: a multifactorial geriatric syndrome. J Am Geriatr Soc (2007) 2.66
Estrogen receptor beta: an overview and update. Nucl Recept Signal (2008) 1.97
Loss of ERbeta expression as a common step in estrogen-dependent tumor progression. Endocr Relat Cancer (2004) 1.84
Estrogen and progestogen use in postmenopausal women: July 2008 position statement of The North American Menopause Society. Menopause (2008) 1.74
Animal models of ovarian cancer. Reprod Biol Endocrinol (2003) 1.57
Social and Cultural Factors Affecting Complementary and Alternative Medicine (CAM) Use during Menopause in Sydney and Bologna. Evid Based Complement Alternat Med (2013) 1.39
Making decisions about hormone replacement therapy. BMJ (2003) 1.38
Estrogen therapy and cognition: a review of the cholinergic hypothesis. Endocr Rev (2009) 1.33
Increased ovarian cancer risk associated with menopausal estrogen therapy is reduced by adding a progestin. Cancer (2009) 1.25
Screening for ovarian cancer: recommendation statement. Ann Fam Med (2004) 1.24
A prospective study of postmenopausal hormone use and ovarian cancer risk. Br J Cancer (2006) 1.23
Benefits and harms associated with hormone replacement therapy: clinical decision analysis. BMJ (2004) 1.18
Diet and risk of ovarian cancer in the California Teachers Study cohort. Am J Epidemiol (2007) 1.16
Tissue-specific pathways for estrogen regulation of ovarian cancer growth and metastasis. Cancer Res (2010) 1.07
Menopausal hormone therapy and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev (2009) 1.07
Aromatase excess in cancers of breast, endometrium and ovary. J Steroid Biochem Mol Biol (2007) 1.06
Association of two common single-nucleotide polymorphisms in the CYP19A1 locus and ovarian cancer risk. Endocr Relat Cancer (2008) 1.06
Stable isotope-coded quaternization for comparative quantification of estrogen metabolites by high-performance liquid chromatography-electrospray ionization mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci (2008) 1.04
Estrogen receptor beta, a possible tumor suppressor involved in ovarian carcinogenesis. Cancer Lett (2006) 1.03
Endogenous n-3 fatty acids protect ovariectomy induced bone loss by attenuating osteoclastogenesis. J Cell Mol Med (2009) 0.99
Endometriosis and ovarian cancer: a review of clinical, pathologic, and molecular aspects. Int J Gynecol Pathol (2011) 0.97
Relationship between epidemiologic risk factors and hormone receptor expression in ovarian cancer: results from the Nurses' Health Study. Cancer Epidemiol Biomarkers Prev (2009) 0.96
Influence of ferutinin on bone metabolism in ovariectomized rats. II: role in recovering osteoporosis. J Anat (2010) 0.96
Alcohol intake and ovarian cancer risk: a pooled analysis of 10 cohort studies. Br J Cancer (2006) 0.95
New insights on the role of hormonal therapy in ovarian cancer. Steroids (2013) 0.94
Hereditary breast and ovarian cancer: new genes in confined pathways. Nat Rev Cancer (2016) 0.94
GPR30 regulates the EGFR-Akt cascade and predicts lower survival in patients with ovarian cancer. J Ovarian Res (2012) 0.94
Influence of ferutinin on bone metabolism in ovariectomized rats. I: role in preventing osteoporosis. J Bone Miner Metab (2009) 0.93
Body size and the risk of ovarian cancer by hormone therapy use in the California Teachers Study cohort. Cancer Causes Control (2010) 0.92
Epigenetic modifications of the Estrogen receptor beta gene in epithelial ovarian cancer cells. Anticancer Res (2009) 0.92
Estrogens, hormone therapy, and hippocampal volume in postmenopausal women. Maturitas (2012) 0.91
Translesion synthesis past equine estrogen-derived 2'-deoxyadenosine DNA adducts by human DNA polymerases eta and kappa. Biochemistry (2006) 0.90
Exposures to synthetic estrogens at different times during the life, and their effect on breast cancer risk. J Mammary Gland Biol Neoplasia (2013) 0.90
Racial differences in stage at diagnosis and survival from epithelial ovarian cancer: a fundamental cause of disease approach. Soc Sci Med (2010) 0.89
Mechanism of translesion synthesis past an equine estrogen-DNA adduct by Y-family DNA polymerases. J Mol Biol (2007) 0.89
Hormone therapy and ovarian cancer: incidence and survival. Cancer Causes Control (2008) 0.88
17β-estradiol upregulates GREB1 and accelerates ovarian tumor progression in vivo. Int J Cancer (2014) 0.87
Bone selective protective effect of a novel bone-seeking estrogen on trabecular bone in ovariectomized rats. Calcif Tissue Int (2013) 0.84
Estrogen, male dominance and esophageal adenocarcinoma: is there a link? World J Gastroenterol (2012) 0.84
Ovarian cancer and menopausal hormone therapy in the NIH-AARP diet and health study. Br J Cancer (2012) 0.84
Discovery of prognostic factors for diagnosis and treatment of epithelial-derived ovarian cancer from laying hens. J Cancer Prev (2013) 0.83
Antiosteoporotic Activity of Dioscorea alata L. cv. Phyto through Driving Mesenchymal Stem Cells Differentiation for Bone Formation. Evid Based Complement Alternat Med (2011) 0.83
Neuroprotective effect of exogenous melatonin on dopaminergic neurons of the substantia nigra in ovariectomized rats. Iran Biomed J (2011) 0.83
Establishing the compliance in elderly women for use of a low level mechanical stress device in a clinical osteoporosis study. Osteoporos Int (2004) 0.82
Safety profile of raloxifene as used in general practice in England: results of a prescription-event monitoring study. Osteoporos Int (2004) 0.82
Estrogen signaling crosstalk: Implications for endocrine resistance in ovarian cancer. J Steroid Biochem Mol Biol (2014) 0.81
Osteogenic effect of high-frequency acceleration on alveolar bone. J Dent Res (2012) 0.80
Peritoneal adhesion and angiogenesis in ovarian carcinoma are inversely regulated by hyaluronan: the role of gonadotropins. Neoplasia (2010) 0.80
Tamoxifen and the risk of ovarian cancer in BRCA1 mutation carriers. Gynecol Oncol (2009) 0.80
In Silico discovery of transcription factors as potential diagnostic biomarkers of ovarian cancer. BMC Syst Biol (2011) 0.80
The functional mechanism of simvastatin in experimental osteoporosis. J Bone Miner Metab (2014) 0.79
Single and multiple ascending dose studies of a novel tissue-selective oestrogen receptor modulator, CHF 4227, in healthy postmenopausal women. Br J Clin Pharmacol (2007) 0.79
Three-dimensional modeling of the human fallopian tube fimbriae. Gynecol Oncol (2014) 0.79
Subtype specific elevated expression of hyaluronidase-1 (HYAL-1) in epithelial ovarian cancer. PLoS One (2011) 0.79
Aerobic exercise and whole-body vibration in offsetting bone loss in older adults. J Aging Res (2011) 0.79
Local estrogen metabolism in epithelial ovarian cancer suggests novel targets for therapy. J Steroid Biochem Mol Biol (2015) 0.79
Levetiracetam for the treatment of hot flashes: a phase II study. Support Care Cancer (2007) 0.79
Influence of exercise on bone remodeling-related hormones and cytokines in ovariectomized rats: a model of postmenopausal osteoporosis. PLoS One (2014) 0.78
Effects of 17β-estradiol and estrogen receptor antagonists on the proliferation of gastric cancer cell lines. J Gastric Cancer (2013) 0.78
Quantitative detection of 4-hydroxyequilenin-DNA adducts in mammalian cells using an immunoassay with a novel monoclonal antibody. Nucleic Acids Res (2010) 0.78
Should symptomatic menopausal women be offered hormone therapy? MedGenMed (2006) 0.78
Bisphenol A and hormone-associated cancers: current progress and perspectives. Medicine (Baltimore) (2015) 0.78
Dysregulated estrogen receptor signaling in the hypothalamic-pituitary-ovarian axis leads to ovarian epithelial tumorigenesis in mice. PLoS Genet (2014) 0.78
Estrogen responsiveness of the TFIID subunit TAF4B in the normal mouse ovary and in ovarian tumors. Biol Reprod (2013) 0.78
17β Hydroxysteroid dehydrogenase type 12 (HSD17B12) is a marker of poor prognosis in ovarian carcinoma. Gynecol Oncol (2012) 0.78
Genome-wide transcriptional regulation of estrogen receptor targets in fallopian tube cells and the role of selective estrogen receptor modulators. J Ovarian Res (2016) 0.76
Estrogen replacement therapy and risk of ovarian cancer in postmenopausal women. JAMA (2002) 0.76
The estrogen controversy. Rev Urol (2003) 0.76
Epidemiology of ovarian cancer: a review. Cancer Biol Med (2017) 0.75
Effect of whole-body vibration on reduction of bone loss and fall prevention in postmenopausal women: a meta-analysis and systematic review. J Orthop Surg Res (2016) 0.75
The Reduction in Circulating Melatonin Level May Contribute to the Pathogenesis of Ovarian Cancer: A Retrospective Study. J Cancer (2016) 0.75
[Evidence based basis of decision making for or against a postmenopausal hormone treatment]. Wien Klin Wochenschr (2004) 0.75
Epithelial ovarian cancer. Risk factors, screening and the role of prophylactic oophorectomy. Hippokratia (2007) 0.75
Effect of dietary legumes on bone-specific gene expression in ovariectomized rats. Nutr Res Pract (2013) 0.75
Pulsed focused ultrasound treatment of muscle mitigates paralysis-induced bone loss in the adjacent bone: a study in a mouse model. Ultrasound Med Biol (2014) 0.75
Estrogen replacement therapy and risk of ovarian cancer. JAMA (2002) 0.75
Equine estrogen-induced mammary tumors in rats. Toxicol Lett (2010) 0.75
Facts and ideas from anywhere. Proc (Bayl Univ Med Cent) (2002) 0.75
Association between alcohol consumption and the risk of ovarian cancer: a meta-analysis of prospective observational studies. BMC Public Health (2015) 0.75
p66Shc longevity protein regulates the proliferation of human ovarian cancer cells. Mol Carcinog (2014) 0.75
Estrogen replacement therapy and risk of ovarian cancer in postmenopausal women. JAMA (2002) 0.75
Differences in risk for type 1 and type 2 ovarian cancer in a large cancer screening trial. J Gynecol Oncol (2016) 0.75
Effects of OsteoKing on osteoporotic rabbits. Mol Med Rep (2015) 0.75
Preventive effect of crocin on osteoporosis in an ovariectomized rat model. Evid Based Complement Alternat Med (2014) 0.75
Conjugated linoleic Acid prevents ovariectomy-induced bone loss in mice by modulating both osteoclastogenesis and osteoblastogenesis. Lipids (2013) 0.75
Replication study for the association of seven genome- GWAS-identified Loci with susceptibility to ovarian cancer in the Polish population. Pathol Oncol Res (2014) 0.75
Ovariectomy differential influence on some hemostatic markers of mice and rats. Exp Anim (2014) 0.75
Bone fractures and incident epithelial ovarian cancer in a prospective cohort study. J Womens Health (Larchmt) (2009) 0.75
A case of ovarian mucinous adenocarcinoma in a premenarcheal girl. Int J Clin Oncol (2011) 0.75
Protective Effects of Female Reproductive Factors on Lauren Intestinal-Type Gastric Adenocarcinoma. Yonsei Med J (2018) 0.75
Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med (2006) 16.17
Body-mass index and mortality among 1.46 million white adults. N Engl J Med (2010) 13.34
Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat Genet (2009) 10.34
Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial. JAMA (2011) 9.13
Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood (2005) 8.37
Structure of dietary measurement error: results of the OPEN biomarker study. Am J Epidemiol (2003) 8.25
50-year trends in smoking-related mortality in the United States. N Engl J Med (2013) 7.80
Using intake biomarkers to evaluate the extent of dietary misreporting in a large sample of adults: the OPEN study. Am J Epidemiol (2003) 7.68
Cancer risks attributable to low doses of ionizing radiation: assessing what we really know. Proc Natl Acad Sci U S A (2003) 7.44
Reporting participation in epidemiologic studies: a survey of practice. Am J Epidemiol (2005) 6.52
Epidemiologic evaluation of measurement data in the presence of detection limits. Environ Health Perspect (2004) 6.43
Meat intake and mortality: a prospective study of over half a million people. Arch Intern Med (2009) 6.42
Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics. PLoS Genet (2008) 6.22
Colonoscopic screening of average-risk women for colorectal neoplasia. N Engl J Med (2005) 5.88
Performance of common genetic variants in breast-cancer risk models. N Engl J Med (2010) 5.79
Smoking and mortality--beyond established causes. N Engl J Med (2015) 5.54
Etiology of hormone receptor-defined breast cancer: a systematic review of the literature. Cancer Epidemiol Biomarkers Prev (2004) 5.32
The Diesel Exhaust in Miners study: a nested case-control study of lung cancer and diesel exhaust. J Natl Cancer Inst (2012) 5.27
Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet (2009) 5.14
Projecting absolute invasive breast cancer risk in white women with a model that includes mammographic density. J Natl Cancer Inst (2006) 4.95
A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat Genet (2010) 4.89
Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA trials. Lancet Oncol (2015) 4.84
ABO blood group and the risk of pancreatic cancer. J Natl Cancer Inst (2009) 4.72
The carcinogenicity of human papillomavirus types reflects viral evolution. Virology (2005) 4.72
The Diesel Exhaust in Miners study: a cohort mortality study with emphasis on lung cancer. J Natl Cancer Inst (2012) 4.65
Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst (2010) 4.54
Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents. Lancet (2016) 4.49
Association between smoking and risk of bladder cancer among men and women. JAMA (2011) 4.31
Differences in risk factors for breast cancer molecular subtypes in a population-based study. Cancer Epidemiol Biomarkers Prev (2007) 4.23
Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium. Lancet Oncol (2006) 4.13
Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection. J Natl Cancer Inst (2010) 3.95
Amount of time spent in sedentary behaviors and cause-specific mortality in US adults. Am J Clin Nutr (2012) 3.95
Proof-of-principle evaluation of the efficacy of fewer than three doses of a bivalent HPV16/18 vaccine. J Natl Cancer Inst (2011) 3.92
Performance of a food-frequency questionnaire in the US NIH-AARP (National Institutes of Health-American Association of Retired Persons) Diet and Health Study. Public Health Nutr (2007) 3.88
Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer. JAMA (2012) 3.85
Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica. J Infect Dis (2005) 3.84
Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nat Genet (2013) 3.81
Dietary fiber intake and mortality in the NIH-AARP diet and health study. Arch Intern Med (2011) 3.77
Cancer risk prediction models: a workshop on development, evaluation, and application. J Natl Cancer Inst (2005) 3.75
Detectable clonal mosaicism and its relationship to aging and cancer. Nat Genet (2012) 3.69
Mediterranean dietary pattern and prediction of all-cause mortality in a US population: results from the NIH-AARP Diet and Health Study. Arch Intern Med (2007) 3.58
Comparisons of HPV DNA detection by MY09/11 PCR methods. J Med Virol (2002) 3.53
Multivitamin use and risk of prostate cancer in the National Institutes of Health-AARP Diet and Health Study. J Natl Cancer Inst (2007) 3.51
A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica. J Infect Dis (2005) 3.46
Human papillomavirus infection with multiple types: pattern of coinfection and risk of cervical disease. J Infect Dis (2011) 3.44
The non-Hodgkin lymphomas: a review of the epidemiologic literature. Int J Cancer (2007) 3.44
Methods for pooling results of epidemiologic studies: the Pooling Project of Prospective Studies of Diet and Cancer. Am J Epidemiol (2006) 3.41
Postpolypectomy colonoscopy surveillance guidelines: predictive accuracy for advanced adenoma at 4 years. Ann Intern Med (2008) 3.34
Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens. Cancer Prev Res (Phila) (2011) 3.33
Diet, nutrition and the prevention of cancer. Public Health Nutr (2004) 3.28
Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial: findings from the initial screen of a randomized trial. Am J Obstet Gynecol (2005) 3.25
A road map for efficient and reliable human genome epidemiology. Nat Genet (2006) 3.21
Multiple human papillomavirus genotype infections in cervical cancer progression in the study to understand cervical cancer early endpoints and determinants. Int J Cancer (2009) 3.15
A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancer. Cancer Prev Res (Phila) (2011) 3.03
I-131 dose response for incident thyroid cancers in Ukraine related to the Chornobyl accident. Environ Health Perspect (2011) 2.95
Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium. Am J Epidemiol (2010) 2.86
Variation of serum prostate-specific antigen levels: an evaluation of year-to-year fluctuations. JAMA (2003) 2.85
Epidemiological study of anti-HPV16/18 seropositivity and subsequent risk of HPV16 and -18 infections. J Natl Cancer Inst (2010) 2.81
A combined analysis of North American case-control studies of residential radon and lung cancer. J Toxicol Environ Health A (2006) 2.78
Dietary fiber intake and risk of colorectal cancer: a pooled analysis of prospective cohort studies. JAMA (2005) 2.76
Physical activity recommendations and decreased risk of mortality. Arch Intern Med (2007) 2.76
Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium. Hum Mol Genet (2011) 2.72
Recent trends in breast cancer among younger women in the United States. J Natl Cancer Inst (2008) 2.72
Cigarette smoking and subsequent risk of lung cancer in men and women: analysis of a prospective cohort study. Lancet Oncol (2008) 2.71
Short term persistence of human papillomavirus and risk of cervical precancer and cancer: population based cohort study. BMJ (2009) 2.68
Prevention of persistent human papillomavirus infection by an HPV16/18 vaccine: a community-based randomized clinical trial in Guanacaste, Costa Rica. Cancer Discov (2011) 2.66
A comparison of two dietary instruments for evaluating the fat-breast cancer relationship. Int J Epidemiol (2006) 2.65
Analysis of colorectal cancer occurrence during surveillance colonoscopy in the dietary Polyp Prevention Trial. Gastrointest Endosc (2005) 2.63
Dietary fat and postmenopausal invasive breast cancer in the National Institutes of Health-AARP Diet and Health Study cohort. J Natl Cancer Inst (2007) 2.63
Probabilities of death from breast cancer and other causes among female breast cancer patients. J Natl Cancer Inst (2004) 2.60
A quantitative approach for estimating exposure to pesticides in the Agricultural Health Study. Ann Occup Hyg (2002) 2.60
Transforming epidemiology for 21st century medicine and public health. Cancer Epidemiol Biomarkers Prev (2013) 2.56
Residential radon and risk of lung cancer: a combined analysis of 7 North American case-control studies. Epidemiology (2005) 2.56
A pooled analysis of advanced colorectal neoplasia diagnoses after colonoscopic polypectomy. Gastroenterology (2008) 2.56
Ongoing colorectal cancer risk despite surveillance colonoscopy: the Polyp Prevention Trial Continued Follow-up Study. Gastrointest Endosc (2009) 2.55
Pooled results from 5 validation studies of dietary self-report instruments using recovery biomarkers for energy and protein intake. Am J Epidemiol (2014) 2.53
Mortality from solid cancers among workers in formaldehyde industries. Am J Epidemiol (2004) 2.50
Colorectal cancers soon after colonoscopy: a pooled multicohort analysis. Gut (2013) 2.50
A prospective study of red and processed meat intake in relation to cancer risk. PLoS Med (2007) 2.49
Etiologic heterogeneity among non-Hodgkin lymphoma subtypes. Blood (2008) 2.49
Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study. Lancet Oncol (2013) 2.48
Positional accuracy of two methods of geocoding. Epidemiology (2005) 2.47
Epidemiology of inflammatory breast cancer (IBC). Breast Dis (2006) 2.46
Impact of occupational carcinogens on lung cancer risk in a general population. Int J Epidemiol (2012) 2.46
Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976-2000. Cancer (2004) 2.46
Leisure time physical activity of moderate to vigorous intensity and mortality: a large pooled cohort analysis. PLoS Med (2012) 2.45
Dealing with dietary measurement error in nutritional cohort studies. J Natl Cancer Inst (2011) 2.43
Mortality from lymphohematopoietic malignancies and brain cancer among embalmers exposed to formaldehyde. J Natl Cancer Inst (2009) 2.42
Formative research of a quick list for an automated self-administered 24-hour dietary recall. J Am Diet Assoc (2007) 2.42
Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32. Nat Genet (2010) 2.37
Relationships of human papillomavirus type, qualitative viral load, and age with cytologic abnormality. Cancer Res (2006) 2.33
Description of a seven-year prospective study of human papillomavirus infection and cervical neoplasia among 10000 women in Guanacaste, Costa Rica,. Rev Panam Salud Publica (2004) 2.33
Methodological issues regarding confounding and exposure misclassification in epidemiological studies of occupational exposures. Am J Ind Med (2007) 2.33
Tobacco smoking, NAT2 acetylation genotype and breast cancer risk. Int J Cancer (2006) 2.31
Proportions of Kaposi sarcoma, selected non-Hodgkin lymphomas, and cervical cancer in the United States occurring in persons with AIDS, 1980-2007. JAMA (2011) 2.31
A prospective study of tobacco, alcohol, and the risk of esophageal and gastric cancer subtypes. Am J Epidemiol (2007) 2.31